Medpace Holdings Inc (NASDAQ: MEDP) shares fell 0.92%, or $1.78 per share, to close Wednesday at $192.03. After opening the day at $192.57, shares of Medpace fluctuated between $193.07 and $189.75. 154,798 shares traded hands an increase from their 30 day average of 142,036. Wednesday’s activity brought Medpace’s market cap to $6,878,382,483.
Medpace is headquartered in Cincinnati, Ohio.
About Medpace Holdings Inc
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.